More importantly, endocrinologists should work coordinately with cardiologists and pharmacologists to establish GLP-1RA-dependent and independent effects in preparation for precisely commencing therapy with GLP-1RAs in suitable targeted patient categories
SGLT2 inhibitors showed strong benefits in reducing hospitalization for heart failure and slowing kidney disease progression
Side effects include menstrual irregularities, breast tenderness, gynecomastia in men, and potential drowsiness or dizziness
Genetic correlation analyses are ongoing
These effects, partially mediated by GLP1R + endothelial and intrahepatic T cells, contribute to cardio-protection in T2DM patients [93]
In women using bioidentical hormone replacement therapy (BHRT), testing allows us to optimize and monitor levels